Peritoneal dialysis (PD) and haemodialysis (HD) are two possible modalities for people with kidney failure commencing dialysis. Only a few randomised controlled trials (RCTs) have evaluated PD versus ...

Peritoneal dialysis (PD) has been widely used in renal replacement therapy (RRT) for end-stage kidney disease (ESKD) and acute kidney injury (AKI) because of its convenience, home implementation, no ...

Emerging evidence supports the overarching hypothesis that a more physiological approach to administering dialysis therapy, including in the home through home hemodialysis or peritoneal dialysis, may ...

Heat sterilization of peritoneal dialysis (PD) fluids leads to partial degradation of the osmotic agent to form reactive carbonyl structures, which significantly reduce the biocompatibility of PD ...

Arteriovenous fistulas (AVFs) are surgically created connections between an artery and a vein, primarily used to facilitate hemodialysis in patients with renal failure. As the global population ages ...

Clinical maturation of arteriovenous fistulas (AVF) is largely determined by the adaptive response of the vein to extreme hemodynamic conditions. Histological and bulk transcriptomic analyses of human ...

Does Cystatin C have a role as metabolic surrogate in peritoneal dialysis beyond its association with residual renal function?

Despite its known benefits, the therapeutic potential of SAL in peritoneal dialysis (PD) -induced peritoneal fibrosis remains unexplored. This study aims to investigate the protective effects of SAL ...

Hemodialysis seems to clear protein-bound solutes more efficiently than peritoneal dialysis; however, the circulating levels of these solutes are lower in patients on peritoneal dialysis.

A significant portion of the elderly population undergoes hemodialysis (HD), and prior studies have compared patient outcomes between peritoneal dialysis (PD) and HD. Despite the benefits of PD, such ...